Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02781935 · ClinicalTrials.gov registry record
Diffusion-Weighted MRI for Liver Metastasis
A clinical trial, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- Completed
- Registry status
- 233
- Enrollment target
NCT02781935: Completed study, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
NCT02781935 is a clinical trial that has completed, run by European Organisation for Research and Treatment of Cancer - EORTC. The registered enrollment target is 233 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02781935 has completed, sponsored by European Organisation for Research and Treatment of Cancer - EORTC.
- COMPLETED
- Registry status
- 233 participants
- Enrollment target
Study Summary
The DREAM study will assess the diagnostic accuracy of diffusion-weighted MRI in combination with other imaging modalities (multiparametric MRI and CT Scan) in determining the true status of disappearing liver metastasis (DLM) detected after conversion systemic therapy for unresectable or borderline resectable colorectal liver metastasis (CRLM).
Interventions
- PROCEDURE DW-MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2016-11 |
| Est. Completion | 2023-09-27 |
What the finished NCT02781935 record still lists
NCT02781935 is an observational study that tracks outcomes without assigning an intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which DW-MRI is the first listed.
NCT02781935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02781935 about?
NCT02781935 is a clinical study titled "Diffusion-Weighted MRI for Liver Metastasis". The DREAM study will assess the diagnostic accuracy of diffusion-weighted MRI in combination with other imaging modalities (multiparametric MRI and CT Scan) in determining the true status of disappearing liver metastasis (DLM) detected after conversion systemic therapy for unresectable or borderline...
What is the current status of trial NCT02781935?
This trial is currently completed. The enrollment target is 233 participants. The study started on 2016-11. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT02781935?
The interventions under investigation include: DW-MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02781935?
This trial is sponsored by European Organisation for Research and Treatment of Cancer - EORTC, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06993844 · 233 participants · Phase 1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NCT07141706 · 233 participants · Phase 1
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia